GoodRx Holdings, Inc. (GDRX) Strengthens Recurring Revenue Base with Companion
Key takeaways
- (GDRX) Strengthens Recurring Revenue Base with Companion Neha Gupta Mon, June 8, 2026 at 12:59 AM GMT+7 2 min read GDRX Good Rx (NASDAQ:GDRX) is one of the top penny stocks to buy in investors’ stock portfolio.
- The company launched Good Rx Companion, a new $14.99-a-month subscription service that helps consumers save on routine healthcare costs.
- GoodRx Companion offers prescription savings on more than 200 common generic medications, as well as savings on cleanings, exams, X-rays, crowns, and other dental services.
Good Rx Holdings, Inc. (GDRX) Strengthens Recurring Revenue Base with Companion Neha Gupta Mon, June 8, 2026 at 12:59 AM GMT+7 2 min read GDRX Good Rx (NASDAQ:GDRX) is one of the top penny stocks to buy in investors’ stock portfolio. On May 27, Good Rx (NASDAQ:GDRX) affirmed its commitment to offering free and low-cost generic medications to the public.
The company launched Good Rx Companion, a new $14.99-a-month subscription service that helps consumers save on routine healthcare costs. The service combines lower drug prices with more affordable access to care and services. The service is tailored for patients managing chronic conditions who take multiple medications.
GoodRx Companion offers prescription savings on more than 200 common generic medications, as well as savings on cleanings, exams, X-rays, crowns, and other dental services. The service will also charge $19 on telehealth visits for common needs such as UTIs, skin care, flu, and other conditions.